Expanded seer registries dataset shows improved survival for decisiondx®-melanoma tested patients compared to untested patients

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced new data from a recent study showing patients tested with decisiondx®-melanoma had improved survival compared to untested patients.

CSTL Ratings Summary

CSTL Quant Ranking